What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?
Author(s) -
Yu Shyr,
Derek Shyr
Publication year - 2020
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2020.1847
Subject(s) - medicine , surrogate endpoint , endpoint determination , end point , cancer , medline , clinical trial , oncology , geometry , mathematics , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom